Sinemia, billed as a competitor to MoviePass with its multi-tiered subscription-based movie ticket offering that started in Europe, announced it will shutter its U.S. operations. Like MoviePass, Sinemia has faced challenges sustaining its subscription model and working out monetization, especially while contending with similar services from theater chains such as AMC with its Stubs A-List offering. In addition, Sinemia has been dealing with a patent lawsuit from MoviePass and a class-action suit from subscribers frustrated by account policies, hidden fees and app problems. Continue reading Sinemia Movie Subscription Service Calls It Quits in the U.S.

A month ago, MoviePass switched its $10 per month unlimited movie plan to one that offers three movies per month, with a limited selection. Now, rival Sinemia is offering a similarly unlimited movie plan — except that it costs $30 per month. With this plan, Sinemia allows the subscriber to see a movie a day, except for IMAX or 3D movies, at whatever theater, and adds the perk of being able to reserve seats. But Sinemia also offers other plans, starting with a basic one at $5 for one movie per month. Continue reading Sinemia Launches a $30 Unlimited Movie Plan in U.S. Market

Istanbul-based Sinemia offers a service similar to MoviePass, but whereas MoviePass subscribers pay $10 per month for up to one movie ticket a day, Sinemia’s members pay the same amount for just two movie tickets per month. MoviePass, however, limits its subscribers to 2D showings and doesn’t include seat selection, while Sinemia offers 3D, 4D, IMAX, and lets its subscribers not only choose seats but purchase up to 30 days in advance. Sinemia also offers a $5 per month option for one 2D ticket per month, or $7 per month for two 2D tickets. Continue reading How Sinemia’s $10/Month Movie Subscription Works in Europe